CAS 109628-14-0

1H-Benzimidazole, 2-(ethylthio)-, hydrobromide (1:1)

Description:

1H-Benzimidazole, 2-(ethylthio)-, hydrobromide (1:1) is a chemical compound characterized by its benzimidazole core, which is a bicyclic structure containing both benzene and imidazole rings. The presence of an ethylthio group at the 2-position of the benzimidazole enhances its solubility and may influence its biological activity. As a hydrobromide salt, it is typically more stable and soluble in polar solvents compared to its free base form. This compound may exhibit various pharmacological properties, making it of interest in medicinal chemistry. Its molecular structure suggests potential interactions with biological targets, which could be explored for therapeutic applications. The CAS number 109628-14-0 uniquely identifies this substance in chemical databases, facilitating research and regulatory compliance. Safety data should be consulted to understand its handling, storage, and potential hazards, as with any chemical compound. Overall, 1H-Benzimidazole, 2-(ethylthio)-, hydrobromide is a notable compound in the realm of organic chemistry and drug development.

Formula: C₉H₁₀N₂S·BrH

InChI: InChI=1S/C9H10N2S.BrH/c1-2-12-9-10-7-5-3-4-6-8(7)11-9;/h3-6H,2H2,1H3,(H,10,11);1H

InChI key: InChIKey=BKUKXOMYGPYFJJ-UHFFFAOYSA-N

SMILES: S(CC)C=1NC=2C(N1)=CC=CC2.Br

Synonyms:

• Metaprot
• 1H-Benzimidazole, 2-(ethylthio)-, hydrobromide (1:1)
• Bemitil
• 1H-Benzimidazole, 2-(ethylthio)-, monohydrobromide
• Betamyl

2-(ethylsulfanyl)-1H-1,3-benzodiazole hydrobromide

CAS: 109628-14-0

Formula: C₉H₁₁BrN₂S

Purity: 97%

Molecular weight: 259.166

Ref: IN-DA0095YL

1H-Benzimidazole, 2-(ethylthio)-, monohydrobromide

CAS: 109628-14-0

2-Ethylthiobenzimidazole is a drug that is used to treat metabolic disorders such as brain functions and bowel diseases. It has antioxidative properties, which may be due to its ability to scavenge reactive oxygen species. 2-Ethylthiobenzimidazole has been shown to have a protective effect on the heart in animal models of congestive heart failure by reducing oxidative stress and improving cardiac function. This drug also exhibits chemiluminescent properties in the presence of hydrogen peroxide and luminol, which could be used for control analysis in pharmacological agents.

Formula: C₉H₁₁BrN₂S

Purity: Min. 95%

Molecular weight: 259.17 g/mol

Ref: 3D-JEA62814